经尿道激光与电切术治疗非肌层浸润性膀胱癌效果及安全性比较的Meta分析

田官强; 程量; 周志豪; 陈衍霖; 梁畅; 雷雨声; 符庭波; 张喜荣; 梁培禾

doi:10.16016/j.1000-5404.201901104

您当前的位置：

首页 >

文章列表页 >

经尿道激光与电切术治疗非肌层浸润性膀胱癌效果及安全性比较的Meta分析

公共卫生与预防医学 | 更新时间：2026-01-09

- 经尿道激光与电切术治疗非肌层浸润性膀胱癌效果及安全性比较的Meta分析
- Efficacy and safety of transurethral laser versus transurethral resection for non-muscle invasive bladder urothelial carcinoma: a meta-analysis
- 第三军医大学学报 2019年41卷第14期页码：1387-1396
- 作者机构：
  
  400010 重庆，重庆医科大学附属第二医院泌尿外科
- 作者简介：
  
  [ 梁培禾，E-mail：lph1972@163.com LIANG Peihe, E-mail:lph1972@163.com
- 基金信息：
  
  重庆市卫生局医学科研计划重点项目(2011-1-054);重庆市基础科学与前沿技术研究(CSTC2017jcyjAX0435);第四批重庆市中青年医学高端后备人才培养计划
- DOI：10.16016/j.1000-5404.201901104
  中图分类号： R699.5; R730.56; R737.14
- 收稿：2019-01-12，
  
  修回：2019-03-15，
  
  纸质出版：2019-07-30
- 稿件说明：
移动端阅览
田官强, 程量, 周志豪, 等. 经尿道激光与电切术治疗非肌层浸润性膀胱癌效果及安全性比较的Meta分析[J]. 第三军医大学学报, 2019,41(14):1387-1396.

Guanqiang TIAN, Liang CHENG, Zhihao ZHOU, et al. Efficacy and safety of transurethral laser versus transurethral resection for non-muscle invasive bladder urothelial carcinoma: a meta-analysis[J]. Journal of Third Military Medical University, 2019, 41(14): 1387-1396.
田官强, 程量, 周志豪, 等. 经尿道激光与电切术治疗非肌层浸润性膀胱癌效果及安全性比较的Meta分析[J]. 第三军医大学学报, 2019,41(14):1387-1396. DOI： 10.16016/j.1000-5404.201901104.

Guanqiang TIAN, Liang CHENG, Zhihao ZHOU, et al. Efficacy and safety of transurethral laser versus transurethral resection for non-muscle invasive bladder urothelial carcinoma: a meta-analysis[J]. Journal of Third Military Medical University, 2019, 41(14): 1387-1396. DOI： 10.16016/j.1000-5404.201901104.

摘要

目的

对比分析经尿道激光与经尿道电切手术对非肌层浸润性膀胱尿路上皮癌(non-muscle invasive bladder cancer

NMIBC)的疗效及安全性。

方法

在PubMed、Cochrane图书馆、Medline、Embase、Web of science、社会科学引文索引、中国期刊网全文数据库(CNKI)、中国生物医学文献数据库、维普医学数据库、万方数据库中，检索NMIBC使用经尿道激光与经尿道电切手术治疗的随机对照研究、半随机对照研究(队列研究和病例对照研究)文献，并使用RevMan 5.3软件对数据进行荟萃分析。

结果

共纳入16篇文献，病例2 570例。对比结果如下：手术时间(MD=-0.70；95%

: -2.78~1.38；

=0.51)及术后尿道狭窄发生率(

=0.70；95%

: 0.24~2.06；

=0.52)差异无统计学意义；术中闭孔神经反射(

=0.05；95%

:0.02~0.10；

0.001)、膀胱穿孔发生率(

=0.11；95%

: 0.04~0.29；

0.001)、术后导尿时间(

= -1.08；95%

:-1.46~-0.71；

0.001)、住院时间(MD= -1.00；95%

: -1.66~-0.34；

=0.003)、膀胱冲洗(

=0.21；95%

: 0.13~0.35；

0.001)、12个月复发率(

=0.67；95%

: 0.48~0.93；

=0.02)及24个月复发率(

=0.60；95%

:0.41~0.86；

=0.005)上激光优于电切。

结论

经尿道激光手术治疗NMIBC术中并发症(闭孔神经反射、膀胱穿孔)发生率、术后复发率低，恢复较快，较经尿道电切术具有一定优势。

Abstract

Objective

To compare the safety and efficacy of transurethral laser and transurethral resection for treatment of non-muscle invasive bladder cancer (NMIBC).

Methods

Randomized controlled trials

cohort studies and case-control studies comparing transurethral laser and transurethral resection of NMIBC were retrieved from PubMed

Medline

Embase

Cochrane Library

Web of Science

Social Science Citation Index

China Journal Full-text Database (CNKI)

Chinese Biomedical Literature Database and VIP medical database. RevMan 5.3 software was used for meta-analysis of the data extracted from the eligible studies.

Results

We retrieved 16 eligible studies involving a total of 2 570 patients from the databases. Meta-analysis of the data from these studies showed no significant difference between the 2 surgical modalities in terms of the operation time (

=-0.70

95%

: -2.78~1.38

=0.51) or the occurrence of postoperative urethral stricture (

=0.70

95%

: 0.24~2.06

=0.52). Compared with transurethral resection

transurethral laser surgery was associated with significantly lower incidences of intraoperative obturator nerve reflex (

=0.05

95%

: 0.02~0.10;

0.001) and bladder perforation (

=0.11

95%

: 0.04~0.29

0.001)

shorter postoperative catheterization time (

=-1.08

95%

: -1.46~-0.71

0.001) and length of hospital stay (

=0.05

95%

: 0.02~0.10

0.001)

and lower rates of bladder irrigation (

=0.21

95%

: 0.13~0.35

0.001) and postoperative recurrence at 12 months (

=0.67

95%

: 0.48~0.93

=0.02) and 24 months (

=0.60

95%

: 0.41~0.86

=0.005).

Conclusion

Transurethral laser surgery for NMIBC

as compared with transurethral resection

is associated with lower incidences of intraoperative complications (obsessive nerve reflex and bladder perforation)

a lower postoperative recurrence rate

and faster postoperative recovery.

关键词

Keywords

references

ANTONI S,FERLAY J, SOERJOMATARAM I, et al . Bladder cancer incidence and mortality: A global overview and recent trends[J ] . Eur Urol, 2017, 71(1): 96-108. DOI: 10.1016/j.eururo.2016.06.010 .

KAMAT A M, HAHNN M, EFSTATHIOU J A, et al . Bladder cancer[J ] . Lancet, 2016, 388(10061): 2796-2810. DOI: 10.1016/S0140-6736(16)30512-8.

BABJUK M, BÖHLE A, BURGER M, et al . EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016[J ] . Eur Urol, 2017, 71(3): 447-461. DOI: 10.1016/j.eururo.2016.05.041.

FLAIG T W, SPIESS P E, AGARWAL N, et al . NCCN guidelines insights: bladder cancer, version 5.2018[J ] . J Natl Compr Canc Netw, 2018, 16(9): 1041-1053. DOI: 10.6004/jnccn.2018.0072.

THALLAJ A, RABAH D. Efficacy of ultrasound-guidedobturator nerve block in transurethral surgery[J]. Saudi J Anaesth, 2011, 5(1): 42-44. DOI: 10.4103/1658-354X.76507.

PIETROW P K, Joseph A, SMITH J R. Laser treatment for invasive and noninvasive carcinoma of the bladder[J]. J Endourol, 2001, 15(4): 415-418. DOI: 10.1089/08927790 1300189466.

SHARMA D, SINGH V P, AGARWAL N, et al . Obturator nerve block in transurethral resection of bladder tumor: A comparative study by two techniques[J ] . Anesth Essays Res, 2017, 11(1): 101-104. DOI: 10.4103/0259-1162.184613.

PIERRE S A, ALBALA DM.The future of lasers in urology[J]. World J Urol, 2007, 25(3): 275-283. DOI: 10.1007/s00345-007-0185-4.

BAI Y, LIU L, YUAN H, et al . Safety and efficacy of trans-urethral laser therapy for bladder cancer: a systematic review and meta-analysis[J ] . World J Surg Oncol, 2014, 12: 301. DOI: 10.1186/1477-7819-12-301.

HERRMANN T R, LIATSIKOS E N, NAGELE U, et al . EAU guidelines on laser technologies[J ] . Eur Urol, 2012, 61(4): 783-795. DOI: 10.1016/j.eururo.2012.01.010.

HOZO S P, DJULBEGOVIC B, HOZO I.Estimating the mean and variance from the median, range, and the size of a sample[J]. BMC Med Res Methodol, 2005, 5: 13. DOI: 10.1186/1471-2288-5-13.

MCCORMICK F, CVETANOVICH G L, KIM J M, et al . An assessment of the quality of rotator cuff randomized controlled trials: utilizing the Jadad score and CONSORT criteria[J ] . J Shoulder Elbow Surg, 2013, 22(9): 1180-1185. DOI: 10.1016/ j.jse.2013.01.017.

SONG X S, YANG D Y, CHE X Y, et al . Comparing the safety and efficiency of conventional monopolar, plasma kinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer[J ] . J Endourol, 2010, 24(1): 69-73. DOI: 10.1089/end.2009.0171.

ZHONG C, GUO S, TANGY, et al . Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience[J ] . World J Urol, 2010, 28(2): 157-161. DOI: 10.1007/s00345-010-0532-8.

LIU H, WU J, XUE S, et al . Comparison of the safety and efficacy of conventionalmonopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer[J ] . J Int Med Res, 2013, 41(4): 984-992. DOI: 10.1177/0300060513477001.

TAO W, YANG D, SHAN Y, et al . Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer[J ] . J Xray Sci Technol, 2013, 21(2): 309-316. DOI: 10.3233/XST-130379.

YANG D, XUE B, ZANG Y, et al . Efficacy and safety of pot assium-titanyl-phosphate laser vaporization for clinically non-muscle invasive bladder cancer[J ] . Urol J, 2014, 11(1): 1258-1263. DOI: 10.1159/000357641.

CHEN X, LIAO J, CHENL, et al . En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: A randomized controlled trial[J ] . World J Urol, 2015, 33(7): 989-995. DOI: 10.1007/s00345-014-1342-1.

MIGLIARI R, BUFFARDI A, GHABIN H. Thulium laser endoscopic en blocenucleation of nonmuscle-invasive bladder cancer[J]. J Endourol, 2015, 29(11): 1258-1262. DOI: 10.1089/end.2015.0336.

XU Y, GUAN W, CHENW, et al . Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study[J ] . Lasers Surg Med, 2015, 47(4): 306-311. DOI: 10.1002/lsm.22342.

ZHANG X R,CHAO F, ZHU W D et al . Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study[J ] . Photomed Laser Surg, 2015, 33(10): 517-523. DOI: 10.1089/pho.2015.3913.

马天加, 王文振, 姜兆群, 等. NBI辅助钬激光与TURBt治疗非肌层浸润性膀胱尿路上皮癌的前瞻性随机对照研究[J].中华医学杂志, 2015, 95(37): 3032-3035. DOI: 10.3760/cma.j.issn.0376-2491.2015.37.008.

MA T J, WANG W Z, JIANG Z Q, et al . Narrow band imaging-assisted holmium laser resection reduced the recurrence rate of non-muscle invasive bladder cancer: a prospective, randomized controlled study[J ] . Natl Med J China, 2015, 95(37): 3032-3035. DOI: 10.3760/cma.j.issn.0376-2491.2015.37.008.

KRAMER M W, RASSWEILER JJ, KLEIN J, et al . En bloc resection of urothelium carcinoma of the bladder (EBRUC): A European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor[J ] . World J Urol, 2015, 33(12): 1937-1943. DOI: 10.1007/s00345-015-1568-6.

CHEN J, ZHAO Y, WANG S, et al . Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethralelectroresection: A prospective, nonrandomized two-center trial with 36-month follow-up[J ] . Lasers Surg Med, 2016, 48(9): 859-865. DOI: 10.1002/lsm.22565.

D'SOUZA N, VERMA A. Holmium laser transurethral resection of bladder tumor: Our experience[J]. Urol Ann, 2016, 8(4): 439-443. DOI: 10.4103/0974-7796.190815.

CHENG B, QIU X, LI H, et al . The safety and efficacy of front-firing green-light laser endoscopic en blocphotoselective vapo-enucleation of non-muscle-invasive bladder cancer[J ] . Ther Clin Risk Manag, 2017, 13: 983-988. DOI: 10.2147/TCRM.S141900.

LI K, XU Y, TAN M, et al . A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer[J ] . Lasers Med Sci, 2019, 34(1): 85-92. DOI: 10.1007/s10103-018-2604-8.

XU H, MA J, CHEN Z, et al . Safety and efficacy of en bloc transurethral resection with 1.9 μm vela laser for treatment of non-muscle-invasive bladder cancer[J ] . Urology, 2018, 113: 246-250. DOI: 10.1016/j.urology.2017.11.030.

SEXTON W J, WIEGAND L R, CORREA JJ, et al . Bladder cancer: a review of non-muscle invasive disease[J ] . Cancer Control, 2010, 17(4): 256-268. DOI: 10.1177/107327481001700406.

MARIAPPAN P, ZACHOU A, GRIGOR K M. Detrusor muscle in the first, apparently complete transurethral resection of bladdertumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience[J]. Eur Urol, 2010, 57(5): 843-849. DOI: 10.1016/j.eururo.2009.05.047.

DE NUNZIO C, FRANCO G, CINDOLO L, et al . Transuretral resection of the bladder (TURB): analysis of complications using a modified clavien system in an italian real life cohort[J ] . Eur J Surg Oncol, 2014, 40(1): 90-95. DOI: 10.1016/j.ejso.2013.11.003.

LU M H, LIU X L. Comparison of GreenLight laser photoselective vaporization and thulium laser enucleation for nonmuscle invasive bladder cancer[J]. Photomed Laser Surg, 2018, 36(7): 383-385. DOI: 10.1089/pho.2018.4440.

KRAMER M W, BACH T, WOLTERS M, et al . Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer[J ] . World J Urol, 2011, 29(4): 433-442. DOI: 10.1007/s00345-011-0680-5.

[LIEM E I M L, FREUND J E, SAVCI-HEIJINK C D, et al . Validation of confocal laser endomicroscopy features of bladder cancer: the next step towards real-time histologic grading[J ] . Eur Urol Focus, 2018, 19, pii: S2405-4569(18)30178-0.DOI: 10.1016/j.euf.2018.07.012 http://dx.doi.org/10.1016/j.euf.2018.07.012 ..

HERMANN GG, MOGENSEN K, ROSTHØJ S. Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis[J]. Scand J Urol, 2018, 52(3): 194-198. DOI: 10.1080/21681805.2018.1450782.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

基于系统评价和Meta分析的糖尿病足溃疡患者截肢风险预测模型的开发和验证

新型冠状病毒肺炎患者转氨酶水平的Meta分析

新型冠状病毒肺炎患者发生重症、危重症危险因素的Meta分析

绿激光直出式剜除和选择性汽化治疗良性前列腺增生症患者的随机对照研究